Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin | 23 | 2023 | 4324 | 2.760 |
Why?
|
Skin Diseases | 12 | 2023 | 1065 | 2.390 |
Why?
|
Calciphylaxis | 10 | 2023 | 122 | 2.260 |
Why?
|
Exanthema | 7 | 2023 | 491 | 1.920 |
Why?
|
Keratin-17 | 4 | 2022 | 26 | 1.740 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 8 | 2016 | 42 | 1.700 |
Why?
|
Sweat Gland Neoplasms | 5 | 2024 | 108 | 1.610 |
Why?
|
Churg-Strauss Syndrome | 2 | 2022 | 70 | 1.580 |
Why?
|
Skin Neoplasms | 21 | 2024 | 5632 | 1.530 |
Why?
|
Encephalocele | 2 | 2023 | 138 | 1.520 |
Why?
|
Drug Eruptions | 4 | 2023 | 295 | 1.330 |
Why?
|
Carcinoma, Basal Cell | 3 | 2022 | 543 | 1.260 |
Why?
|
Psoriasis | 4 | 2023 | 888 | 1.260 |
Why?
|
Dermis | 3 | 2021 | 205 | 1.180 |
Why?
|
Scleritis | 2 | 2020 | 100 | 1.070 |
Why?
|
Scleroderma, Diffuse | 2 | 2015 | 16 | 1.060 |
Why?
|
Eosinophilia | 2 | 2022 | 531 | 1.050 |
Why?
|
Eczema | 2 | 2023 | 225 | 0.900 |
Why?
|
Keloid | 2 | 2020 | 50 | 0.890 |
Why?
|
Melanocytes | 4 | 2018 | 514 | 0.860 |
Why?
|
Cicatrix, Hypertrophic | 2 | 2020 | 75 | 0.850 |
Why?
|
Carcinoma, Squamous Cell | 7 | 2024 | 4014 | 0.840 |
Why?
|
Nevus | 1 | 2024 | 203 | 0.830 |
Why?
|
Acantholysis | 1 | 2021 | 11 | 0.820 |
Why?
|
Th17 Cells | 3 | 2017 | 760 | 0.800 |
Why?
|
Diagnosis, Differential | 20 | 2022 | 12948 | 0.800 |
Why?
|
Meninges | 1 | 2023 | 190 | 0.790 |
Why?
|
Anus Neoplasms | 2 | 2016 | 329 | 0.780 |
Why?
|
Colostomy | 1 | 2021 | 98 | 0.780 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2017 | 986 | 0.760 |
Why?
|
Pemphigus | 1 | 2021 | 105 | 0.740 |
Why?
|
Herpesvirus 3, Human | 1 | 2021 | 207 | 0.740 |
Why?
|
Vasculitis | 2 | 2017 | 519 | 0.730 |
Why?
|
Herpesvirus 2, Human | 1 | 2021 | 185 | 0.730 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 2019 | 19 | 0.720 |
Why?
|
Tinea Capitis | 1 | 2019 | 12 | 0.720 |
Why?
|
Scalp | 3 | 2021 | 376 | 0.700 |
Why?
|
Antibodies, Antinuclear | 2 | 2020 | 325 | 0.690 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2020 | 58 | 0.690 |
Why?
|
Hair Follicle | 1 | 2021 | 208 | 0.680 |
Why?
|
Sarcoma, Kaposi | 3 | 2017 | 365 | 0.670 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2019 | 150 | 0.650 |
Why?
|
Pathology | 1 | 2021 | 272 | 0.640 |
Why?
|
Herpes Simplex | 1 | 2021 | 466 | 0.640 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2017 | 4400 | 0.630 |
Why?
|
Alopecia | 2 | 2021 | 376 | 0.630 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2020 | 285 | 0.630 |
Why?
|
Cicatrix | 2 | 2020 | 750 | 0.600 |
Why?
|
Antigens, Differentiation | 2 | 2017 | 925 | 0.590 |
Why?
|
Dermatitis, Atopic | 2 | 2015 | 644 | 0.580 |
Why?
|
Urticaria | 2 | 2016 | 150 | 0.580 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2017 | 180 | 0.580 |
Why?
|
Scleroderma, Localized | 1 | 2017 | 78 | 0.570 |
Why?
|
Fasciitis | 1 | 2017 | 65 | 0.570 |
Why?
|
Kidney Failure, Chronic | 6 | 2019 | 2546 | 0.560 |
Why?
|
Stromal Cells | 1 | 2021 | 1350 | 0.540 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 743 | 0.540 |
Why?
|
Temporal Arteries | 1 | 2017 | 128 | 0.540 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2016 | 140 | 0.540 |
Why?
|
Immunohistochemistry | 16 | 2022 | 11347 | 0.540 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2019 | 370 | 0.530 |
Why?
|
Dermatitis, Exfoliative | 1 | 2015 | 28 | 0.530 |
Why?
|
Dermatitis | 1 | 2017 | 195 | 0.530 |
Why?
|
Proto-Oncogene Proteins c-kit | 3 | 2017 | 774 | 0.530 |
Why?
|
Neoplasms, Basal Cell | 1 | 2015 | 31 | 0.530 |
Why?
|
Telepathology | 2 | 2014 | 75 | 0.520 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2016 | 166 | 0.520 |
Why?
|
Infant, Newborn, Diseases | 1 | 2021 | 578 | 0.520 |
Why?
|
Cultural Diversity | 1 | 2019 | 357 | 0.520 |
Why?
|
Biopsy | 17 | 2021 | 6722 | 0.510 |
Why?
|
Th1 Cells | 2 | 2017 | 1055 | 0.510 |
Why?
|
Congresses as Topic | 1 | 2019 | 760 | 0.510 |
Why?
|
Wound Healing | 4 | 2020 | 2768 | 0.500 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1197 | 0.490 |
Why?
|
Carcinoma, Basosquamous | 1 | 2013 | 7 | 0.480 |
Why?
|
Keratin-14 | 1 | 2013 | 57 | 0.470 |
Why?
|
Melanoma | 10 | 2018 | 5446 | 0.470 |
Why?
|
Th2 Cells | 2 | 2016 | 1048 | 0.470 |
Why?
|
Physicians, Women | 1 | 2019 | 483 | 0.460 |
Why?
|
Immunoglobulin G | 3 | 2018 | 4522 | 0.450 |
Why?
|
Sarcoma, Myeloid | 1 | 2013 | 59 | 0.450 |
Why?
|
Dermatology | 2 | 2021 | 871 | 0.450 |
Why?
|
Remote Consultation | 2 | 2014 | 239 | 0.440 |
Why?
|
Scleroderma, Systemic | 3 | 2023 | 312 | 0.440 |
Why?
|
Humans | 103 | 2024 | 739398 | 0.440 |
Why?
|
Granuloma Annulare | 1 | 2013 | 27 | 0.440 |
Why?
|
Sweet Syndrome | 1 | 2013 | 47 | 0.440 |
Why?
|
Adenocarcinoma | 2 | 2024 | 6318 | 0.440 |
Why?
|
Gadolinium | 4 | 2013 | 951 | 0.430 |
Why?
|
Thyroid Diseases | 1 | 2016 | 378 | 0.430 |
Why?
|
Kaposi Varicelliform Eruption | 1 | 2012 | 48 | 0.410 |
Why?
|
Male | 63 | 2024 | 349022 | 0.410 |
Why?
|
Autoimmune Diseases | 2 | 2016 | 2116 | 0.410 |
Why?
|
Hedgehog Proteins | 1 | 2016 | 774 | 0.410 |
Why?
|
Caveolin 1 | 1 | 2013 | 264 | 0.400 |
Why?
|
Minority Groups | 1 | 2019 | 1197 | 0.390 |
Why?
|
Onychomycosis | 1 | 2011 | 47 | 0.390 |
Why?
|
Aged | 40 | 2023 | 162698 | 0.390 |
Why?
|
Substance Abuse, Intravenous | 1 | 2015 | 523 | 0.380 |
Why?
|
Herpes Zoster | 1 | 2013 | 267 | 0.370 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2017 | 2102 | 0.370 |
Why?
|
Middle Aged | 44 | 2023 | 212863 | 0.360 |
Why?
|
Piperazines | 1 | 2020 | 2480 | 0.350 |
Why?
|
Adenoma, Sweat Gland | 1 | 2009 | 18 | 0.340 |
Why?
|
Female | 60 | 2024 | 378853 | 0.340 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 643 | 0.340 |
Why?
|
Pyridines | 1 | 2020 | 2810 | 0.320 |
Why?
|
Complement System Proteins | 1 | 2011 | 799 | 0.310 |
Why?
|
Carcinoma in Situ | 1 | 2014 | 799 | 0.310 |
Why?
|
Adult | 33 | 2023 | 213394 | 0.300 |
Why?
|
Societies, Medical | 1 | 2019 | 3739 | 0.300 |
Why?
|
Retrospective Studies | 19 | 2023 | 76631 | 0.290 |
Why?
|
Specimen Handling | 1 | 2011 | 692 | 0.280 |
Why?
|
Aged, 80 and over | 17 | 2021 | 57650 | 0.270 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3504 | 0.270 |
Why?
|
Pathology, Clinical | 4 | 2014 | 363 | 0.270 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3694 | 0.270 |
Why?
|
Renal Insufficiency, Chronic | 5 | 2023 | 2216 | 0.260 |
Why?
|
Calcium | 1 | 2018 | 5742 | 0.260 |
Why?
|
Warfarin | 2 | 2014 | 1484 | 0.260 |
Why?
|
Kidney Diseases | 2 | 2015 | 2140 | 0.240 |
Why?
|
Hyperpigmentation | 2 | 2015 | 109 | 0.230 |
Why?
|
Arthralgia | 2 | 2020 | 457 | 0.230 |
Why?
|
Asthma | 1 | 2022 | 5950 | 0.230 |
Why?
|
Fatal Outcome | 5 | 2015 | 1850 | 0.220 |
Why?
|
Burns | 3 | 2020 | 1808 | 0.220 |
Why?
|
Myelodysplastic Syndromes | 1 | 2013 | 1345 | 0.220 |
Why?
|
Relaxin | 1 | 2022 | 36 | 0.220 |
Why?
|
Purpura | 2 | 2015 | 122 | 0.210 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 1777 | 0.210 |
Why?
|
Receptors, Calcitriol | 2 | 2016 | 350 | 0.210 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13635 | 0.210 |
Why?
|
Intertrigo | 1 | 2021 | 2 | 0.210 |
Why?
|
Pathology, Surgical | 2 | 2014 | 151 | 0.210 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2021 | 71 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2016 | 8400 | 0.200 |
Why?
|
Myxoma | 1 | 2022 | 130 | 0.200 |
Why?
|
Signal Transduction | 5 | 2019 | 23355 | 0.200 |
Why?
|
Lichen Planus | 1 | 2021 | 57 | 0.190 |
Why?
|
Leg | 2 | 2020 | 1107 | 0.190 |
Why?
|
Phenotype | 4 | 2023 | 16301 | 0.180 |
Why?
|
Internship and Residency | 2 | 2019 | 5761 | 0.180 |
Why?
|
Ribosomal Protein S6 | 2 | 2017 | 70 | 0.180 |
Why?
|
Eccrine Glands | 1 | 2020 | 45 | 0.180 |
Why?
|
Ichthyosis | 1 | 2019 | 58 | 0.180 |
Why?
|
Blood Sedimentation | 1 | 2020 | 232 | 0.170 |
Why?
|
STAT Transcription Factors | 1 | 2019 | 181 | 0.170 |
Why?
|
Skull Neoplasms | 1 | 2020 | 173 | 0.170 |
Why?
|
Fibrosis | 4 | 2023 | 2024 | 0.170 |
Why?
|
Poroma | 1 | 2018 | 3 | 0.170 |
Why?
|
Hematuria | 1 | 2020 | 234 | 0.170 |
Why?
|
Janus Kinases | 1 | 2019 | 244 | 0.160 |
Why?
|
Antibodies, Monoclonal | 2 | 2014 | 9259 | 0.160 |
Why?
|
Heart Neoplasms | 1 | 2022 | 374 | 0.160 |
Why?
|
Lentigo | 1 | 2018 | 37 | 0.160 |
Why?
|
Edema | 2 | 2015 | 791 | 0.160 |
Why?
|
Treponema pallidum | 1 | 2018 | 40 | 0.160 |
Why?
|
Arthritis | 2 | 2016 | 657 | 0.160 |
Why?
|
Carcinoma | 2 | 2020 | 2361 | 0.160 |
Why?
|
Contrast Media | 7 | 2015 | 5293 | 0.160 |
Why?
|
Nail Diseases | 1 | 2018 | 51 | 0.150 |
Why?
|
False Negative Reactions | 1 | 2018 | 589 | 0.150 |
Why?
|
Herpesvirus 8, Human | 2 | 2017 | 258 | 0.150 |
Why?
|
Telangiectasis | 1 | 2017 | 75 | 0.150 |
Why?
|
Neurothekeoma | 1 | 2016 | 7 | 0.150 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2013 | 3485 | 0.150 |
Why?
|
Hypergammaglobulinemia | 1 | 2017 | 74 | 0.150 |
Why?
|
Symbiosis | 1 | 2019 | 285 | 0.150 |
Why?
|
Thrombophilia | 1 | 2020 | 305 | 0.150 |
Why?
|
Deoxyribonucleases | 1 | 2018 | 213 | 0.150 |
Why?
|
Carboxylic Acids | 1 | 2017 | 99 | 0.140 |
Why?
|
Musculoskeletal Diseases | 1 | 2022 | 580 | 0.140 |
Why?
|
Sweating | 1 | 2017 | 123 | 0.140 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1674 | 0.140 |
Why?
|
Thumb | 1 | 2018 | 227 | 0.140 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6726 | 0.140 |
Why?
|
Salivary Glands | 1 | 2017 | 227 | 0.140 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2017 | 67 | 0.140 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2016 | 2015 | 0.140 |
Why?
|
Sjogren's Syndrome | 1 | 2017 | 229 | 0.130 |
Why?
|
Anticoagulants | 2 | 2020 | 4582 | 0.130 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2016 | 87 | 0.130 |
Why?
|
Uremia | 2 | 2015 | 200 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2020 | 15500 | 0.130 |
Why?
|
Syphilis | 1 | 2018 | 225 | 0.130 |
Why?
|
Scleromyxedema | 1 | 2015 | 8 | 0.130 |
Why?
|
Mouth | 1 | 2018 | 372 | 0.130 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 552 | 0.130 |
Why?
|
Phosphorylation | 5 | 2019 | 8416 | 0.130 |
Why?
|
Selection, Genetic | 1 | 2020 | 915 | 0.130 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1476 | 0.130 |
Why?
|
Triamcinolone Acetonide | 1 | 2015 | 101 | 0.130 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2016 | 190 | 0.130 |
Why?
|
Colitis, Ischemic | 1 | 2015 | 31 | 0.130 |
Why?
|
Mycobacterium chelonae | 1 | 2014 | 11 | 0.130 |
Why?
|
Hypothermia, Induced | 1 | 2020 | 746 | 0.130 |
Why?
|
Hypersensitivity, Delayed | 1 | 2015 | 485 | 0.130 |
Why?
|
Colchicine | 1 | 2016 | 240 | 0.130 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 3603 | 0.130 |
Why?
|
GATA3 Transcription Factor | 1 | 2015 | 157 | 0.130 |
Why?
|
Heroin Dependence | 1 | 2015 | 175 | 0.130 |
Why?
|
DNA, Viral | 1 | 2021 | 2223 | 0.130 |
Why?
|
Necrosis | 3 | 2019 | 1643 | 0.120 |
Why?
|
Young Adult | 10 | 2021 | 56255 | 0.120 |
Why?
|
Autopsy | 2 | 2009 | 1004 | 0.120 |
Why?
|
Vitamin K | 1 | 2017 | 291 | 0.120 |
Why?
|
Leg Injuries | 1 | 2016 | 178 | 0.120 |
Why?
|
Splenic Neoplasms | 1 | 2015 | 100 | 0.120 |
Why?
|
Eye Diseases | 1 | 2020 | 670 | 0.120 |
Why?
|
Chronic Disease | 3 | 2019 | 9133 | 0.120 |
Why?
|
Gout Suppressants | 1 | 2016 | 158 | 0.120 |
Why?
|
Synovitis | 1 | 2016 | 209 | 0.120 |
Why?
|
Calcitriol | 1 | 2015 | 298 | 0.120 |
Why?
|
Lasers | 1 | 2018 | 945 | 0.120 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2014 | 87 | 0.120 |
Why?
|
Mastocytosis | 1 | 2016 | 159 | 0.120 |
Why?
|
Pharyngitis | 1 | 2015 | 214 | 0.120 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2016 | 449 | 0.120 |
Why?
|
Materials Testing | 1 | 2017 | 864 | 0.120 |
Why?
|
Body Height | 1 | 2020 | 1577 | 0.120 |
Why?
|
Skin Pigmentation | 1 | 2015 | 281 | 0.110 |
Why?
|
Digestive System Neoplasms | 1 | 2013 | 87 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1117 | 0.110 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.110 |
Why?
|
Ioxaglic Acid | 1 | 2012 | 30 | 0.110 |
Why?
|
Head and Neck Neoplasms | 2 | 2020 | 2706 | 0.110 |
Why?
|
Pruritus | 1 | 2016 | 352 | 0.110 |
Why?
|
Adjuvants, Immunologic | 1 | 2018 | 995 | 0.110 |
Why?
|
Lymphocyte Count | 1 | 2015 | 791 | 0.110 |
Why?
|
Spinal Neoplasms | 1 | 2020 | 758 | 0.110 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15036 | 0.110 |
Why?
|
Skin Ulcer | 1 | 2014 | 118 | 0.110 |
Why?
|
Panniculitis | 1 | 2013 | 42 | 0.110 |
Why?
|
Metaplasia | 1 | 2013 | 313 | 0.110 |
Why?
|
Skin Diseases, Vascular | 1 | 2013 | 39 | 0.110 |
Why?
|
T-Box Domain Proteins | 1 | 2015 | 468 | 0.110 |
Why?
|
Histiocytes | 1 | 2013 | 103 | 0.110 |
Why?
|
Giant Cells | 1 | 2013 | 187 | 0.110 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2017 | 699 | 0.110 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 847 | 0.110 |
Why?
|
Biopsy, Needle | 3 | 2017 | 1637 | 0.110 |
Why?
|
Molluscum Contagiosum | 1 | 2012 | 13 | 0.110 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2013 | 417 | 0.110 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2010 | 215 | 0.110 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2017 | 838 | 0.110 |
Why?
|
Africa, Eastern | 1 | 2012 | 71 | 0.110 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1100 | 0.110 |
Why?
|
Uveitis | 1 | 2016 | 377 | 0.110 |
Why?
|
STAT3 Transcription Factor | 2 | 2015 | 875 | 0.100 |
Why?
|
Pancytopenia | 1 | 2013 | 104 | 0.100 |
Why?
|
Sodium Hydroxide | 1 | 2011 | 43 | 0.100 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1078 | 0.100 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 814 | 0.100 |
Why?
|
Nevus, Blue | 1 | 2011 | 35 | 0.100 |
Why?
|
Adolescent | 8 | 2021 | 85405 | 0.100 |
Why?
|
Docosahexaenoic Acids | 1 | 2018 | 873 | 0.100 |
Why?
|
Drug Resistance | 1 | 2017 | 1610 | 0.100 |
Why?
|
Interleukin-17 | 1 | 2017 | 894 | 0.100 |
Why?
|
beta Catenin | 1 | 2016 | 1057 | 0.100 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2010 | 251 | 0.100 |
Why?
|
Codon | 1 | 2013 | 613 | 0.100 |
Why?
|
Streptococcal Infections | 1 | 2015 | 635 | 0.100 |
Why?
|
Databases, Factual | 2 | 2018 | 7690 | 0.100 |
Why?
|
Gene Frequency | 2 | 2020 | 3585 | 0.100 |
Why?
|
Mutation | 4 | 2024 | 29658 | 0.100 |
Why?
|
CD4 Lymphocyte Count | 1 | 2017 | 2602 | 0.100 |
Why?
|
Mutation, Missense | 1 | 2020 | 2552 | 0.090 |
Why?
|
Ki-67 Antigen | 2 | 2011 | 642 | 0.090 |
Why?
|
Microscopy | 2 | 2014 | 899 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 648 | 0.090 |
Why?
|
MART-1 Antigen | 1 | 2010 | 66 | 0.090 |
Why?
|
Introns | 1 | 2013 | 992 | 0.090 |
Why?
|
Tissue Scaffolds | 1 | 2017 | 952 | 0.090 |
Why?
|
Melanoma-Specific Antigens | 1 | 2010 | 80 | 0.090 |
Why?
|
Nevus, Pigmented | 1 | 2012 | 218 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 493 | 0.090 |
Why?
|
Vaccines | 1 | 2018 | 802 | 0.090 |
Why?
|
Oncogenes | 2 | 2019 | 1264 | 0.090 |
Why?
|
Hamartoma | 1 | 2011 | 236 | 0.090 |
Why?
|
Glycosaminoglycans | 1 | 2012 | 624 | 0.090 |
Why?
|
Fatigue | 1 | 2017 | 1524 | 0.090 |
Why?
|
Observer Variation | 2 | 2014 | 2589 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2012 | 592 | 0.090 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1734 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2948 | 0.090 |
Why?
|
Deglutition Disorders | 1 | 2015 | 607 | 0.080 |
Why?
|
Headache | 1 | 2017 | 1199 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 2971 | 0.080 |
Why?
|
Surgical Flaps | 1 | 2017 | 1627 | 0.080 |
Why?
|
Mast Cells | 1 | 2016 | 1542 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 2986 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3752 | 0.080 |
Why?
|
Protein Array Analysis | 1 | 2010 | 411 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 2015 | 1383 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 2 | 2010 | 1082 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 1585 | 0.080 |
Why?
|
Hospitals, General | 1 | 2012 | 744 | 0.080 |
Why?
|
Thigh | 1 | 2009 | 249 | 0.080 |
Why?
|
Bacteremia | 1 | 2014 | 957 | 0.080 |
Why?
|
Diagnostic Errors | 4 | 2018 | 1253 | 0.080 |
Why?
|
Prognosis | 4 | 2023 | 28901 | 0.080 |
Why?
|
Dendritic Cells | 1 | 2018 | 2728 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1673 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 2016 | 1359 | 0.070 |
Why?
|
Cell Count | 1 | 2011 | 1833 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1122 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2015 | 20055 | 0.070 |
Why?
|
Chromosome Aberrations | 1 | 2013 | 1812 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 35326 | 0.070 |
Why?
|
Bleomycin | 2 | 2022 | 496 | 0.070 |
Why?
|
Heparin | 1 | 2014 | 1637 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3510 | 0.070 |
Why?
|
Prednisone | 1 | 2011 | 1560 | 0.070 |
Why?
|
Surgical Wound Infection | 1 | 2015 | 1530 | 0.070 |
Why?
|
Massachusetts | 3 | 2019 | 8669 | 0.070 |
Why?
|
Gadolinium DTPA | 1 | 2009 | 836 | 0.070 |
Why?
|
DNA-Binding Proteins | 3 | 2015 | 9622 | 0.070 |
Why?
|
Bone Diseases, Metabolic | 1 | 2010 | 417 | 0.070 |
Why?
|
Child, Preschool | 4 | 2018 | 40802 | 0.070 |
Why?
|
Feasibility Studies | 2 | 2014 | 5058 | 0.070 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 2897 | 0.070 |
Why?
|
Sex Factors | 1 | 2019 | 10398 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2727 | 0.070 |
Why?
|
Weight Loss | 1 | 2017 | 2589 | 0.070 |
Why?
|
Creatinine | 1 | 2011 | 1903 | 0.070 |
Why?
|
Gastric Bypass | 1 | 2014 | 809 | 0.070 |
Why?
|
Cartilage, Articular | 1 | 2012 | 1093 | 0.070 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1997 | 0.060 |
Why?
|
Fever | 1 | 2012 | 1607 | 0.060 |
Why?
|
Rats | 6 | 2022 | 24270 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2394 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2277 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1191 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1431 | 0.060 |
Why?
|
Animals | 15 | 2022 | 168368 | 0.060 |
Why?
|
United States | 3 | 2019 | 69573 | 0.060 |
Why?
|
Antigens, CD | 1 | 2013 | 4024 | 0.050 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2022 | 26 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1899 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 2010 | 1977 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2011 | 2100 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2021 | 62693 | 0.050 |
Why?
|
Renal Dialysis | 2 | 2023 | 1780 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8605 | 0.050 |
Why?
|
Macrophages | 1 | 2016 | 5631 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3143 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3248 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3344 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2013 | 5830 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2015 | 21694 | 0.050 |
Why?
|
Lower Extremity | 2 | 2021 | 1145 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4935 | 0.050 |
Why?
|
Buttocks | 1 | 2021 | 110 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2010 | 2965 | 0.050 |
Why?
|
Immunocompromised Host | 2 | 2019 | 845 | 0.050 |
Why?
|
Microfibrils | 1 | 2020 | 17 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2021 | 25470 | 0.050 |
Why?
|
Indians, South American | 1 | 2020 | 36 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2261 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3497 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10945 | 0.050 |
Why?
|
Child | 4 | 2018 | 77033 | 0.050 |
Why?
|
Disease Progression | 3 | 2015 | 13237 | 0.050 |
Why?
|
Erythema | 1 | 2021 | 254 | 0.040 |
Why?
|
Interleukin-13 | 1 | 2022 | 388 | 0.040 |
Why?
|
Heredity | 1 | 2020 | 153 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 489 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8274 | 0.040 |
Why?
|
Carcinoma, Ductal | 1 | 2020 | 101 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 3757 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4832 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12237 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2009 | 2370 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 5462 | 0.040 |
Why?
|
Reproducibility of Results | 5 | 2018 | 19811 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2022 | 962 | 0.040 |
Why?
|
Injections, Intradermal | 1 | 2018 | 117 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8791 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 24714 | 0.040 |
Why?
|
Abdominal Wall | 1 | 2020 | 155 | 0.040 |
Why?
|
Anal Canal | 1 | 2021 | 373 | 0.040 |
Why?
|
Histones | 1 | 2009 | 2591 | 0.040 |
Why?
|
Hutchinson's Melanotic Freckle | 1 | 2018 | 19 | 0.040 |
Why?
|
Fluorouracil | 1 | 2023 | 1609 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2015 | 15511 | 0.040 |
Why?
|
Risk Factors | 6 | 2020 | 71974 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3233 | 0.040 |
Why?
|
Remission Induction | 2 | 2015 | 2378 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Pilot Projects | 3 | 2018 | 8275 | 0.040 |
Why?
|
Ion Channels | 1 | 2022 | 1056 | 0.040 |
Why?
|
Factor VIII | 1 | 2020 | 348 | 0.040 |
Why?
|
Blood Proteins | 2 | 2020 | 1122 | 0.040 |
Why?
|
Peru | 1 | 2020 | 879 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2015 | 5147 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5502 | 0.040 |
Why?
|
Bone Density | 1 | 2010 | 3471 | 0.040 |
Why?
|
Bacteriological Techniques | 1 | 2018 | 277 | 0.040 |
Why?
|
Receptor, Notch1 | 1 | 2020 | 501 | 0.040 |
Why?
|
Genome, Human | 1 | 2010 | 4419 | 0.040 |
Why?
|
Granulation Tissue | 1 | 2016 | 93 | 0.040 |
Why?
|
Tryptases | 1 | 2017 | 190 | 0.040 |
Why?
|
Swine | 2 | 2017 | 5901 | 0.040 |
Why?
|
Lung | 1 | 2015 | 9782 | 0.030 |
Why?
|
Antistreptolysin | 1 | 2015 | 7 | 0.030 |
Why?
|
Mice | 6 | 2022 | 81002 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17384 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 888 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 19220 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1997 | 526 | 0.030 |
Why?
|
Gene Amplification | 2 | 2010 | 1061 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18003 | 0.030 |
Why?
|
Bandages | 1 | 2017 | 258 | 0.030 |
Why?
|
Thiosulfates | 1 | 2015 | 52 | 0.030 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2015 | 45 | 0.030 |
Why?
|
Swine, Miniature | 1 | 2017 | 954 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2303 | 0.030 |
Why?
|
Mohs Surgery | 1 | 2017 | 197 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1602 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1059 | 0.030 |
Why?
|
Plasma Cells | 1 | 2018 | 591 | 0.030 |
Why?
|
Cytokines | 2 | 2022 | 7298 | 0.030 |
Why?
|
Electrolytes | 1 | 2015 | 282 | 0.030 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2015 | 126 | 0.030 |
Why?
|
Arterioles | 1 | 2015 | 253 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2018 | 1894 | 0.030 |
Why?
|
Photography | 1 | 2017 | 518 | 0.030 |
Why?
|
Administration, Topical | 1 | 2015 | 687 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 29002 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 21507 | 0.030 |
Why?
|
Klebsiella Infections | 1 | 2014 | 136 | 0.030 |
Why?
|
Oligodendroglia | 1 | 1997 | 519 | 0.030 |
Why?
|
Interferons | 1 | 2017 | 703 | 0.030 |
Why?
|
Debridement | 1 | 2015 | 491 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10362 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 2 | 2017 | 8299 | 0.030 |
Why?
|
Klebsiella pneumoniae | 1 | 2014 | 244 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3844 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2011 | 5003 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 20676 | 0.030 |
Why?
|
Phototherapy | 1 | 2015 | 372 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 2012 | 380 | 0.030 |
Why?
|
Smad3 Protein | 1 | 2012 | 178 | 0.030 |
Why?
|
Cations | 1 | 2012 | 231 | 0.030 |
Why?
|
Fibroblasts | 1 | 2023 | 4137 | 0.030 |
Why?
|
Dermatologic Agents | 1 | 2015 | 274 | 0.030 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2011 | 63 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2014 | 15194 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2018 | 2634 | 0.030 |
Why?
|
Anemia, Sickle Cell | 1 | 2020 | 1015 | 0.030 |
Why?
|
Infant | 1 | 2013 | 34923 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 694 | 0.030 |
Why?
|
RNA, Viral | 1 | 2019 | 2907 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 16764 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 625 | 0.020 |
Why?
|
Device Removal | 1 | 2015 | 648 | 0.020 |
Why?
|
Phosphorus Isotopes | 1 | 2010 | 126 | 0.020 |
Why?
|
Sarcoidosis | 1 | 2016 | 507 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14740 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2694 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2012 | 390 | 0.020 |
Why?
|
Transcription Factors | 1 | 2010 | 12120 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 618 | 0.020 |
Why?
|
Rare Diseases | 1 | 2015 | 553 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 831 | 0.020 |
Why?
|
Epidermis | 1 | 2012 | 523 | 0.020 |
Why?
|
Steroids | 1 | 2015 | 925 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2016 | 14558 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15153 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1735 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2010 | 496 | 0.020 |
Why?
|
Malnutrition | 1 | 2015 | 613 | 0.020 |
Why?
|
Shock, Septic | 1 | 2015 | 764 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2345 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1018 | 0.020 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2012 | 664 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2015 | 981 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 689 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2009 | 38942 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2012 | 1033 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4211 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2020 | 2091 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3571 | 0.020 |
Why?
|
Gene Deletion | 2 | 2010 | 2757 | 0.020 |
Why?
|
Genes, ras | 1 | 2010 | 693 | 0.020 |
Why?
|
Biological Specimen Banks | 1 | 2012 | 692 | 0.020 |
Why?
|
Cattle | 1 | 2012 | 3913 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 21863 | 0.020 |
Why?
|
Vaccination | 1 | 2018 | 3232 | 0.020 |
Why?
|
Rabbits | 1 | 2012 | 4882 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1754 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4424 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7726 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2999 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8039 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1327 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1251 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7862 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3562 | 0.020 |
Why?
|
Indoles | 1 | 2013 | 1832 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2010 | 1178 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 2028 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3138 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9684 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 1997 | 4463 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7897 | 0.010 |
Why?
|
Sulfonamides | 1 | 2013 | 1934 | 0.010 |
Why?
|
Cohort Studies | 2 | 2019 | 40389 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3692 | 0.010 |
Why?
|
Thromboembolism | 1 | 2009 | 984 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 23294 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4182 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2017 | 10961 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2006 | 1166 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2381 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3922 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12178 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4205 | 0.010 |
Why?
|
Software | 1 | 2014 | 4423 | 0.010 |
Why?
|
Osteoporosis | 1 | 2010 | 1576 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 2936 | 0.010 |
Why?
|
Internal Medicine | 1 | 2006 | 996 | 0.010 |
Why?
|
Cause of Death | 1 | 2009 | 3564 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2012 | 3514 | 0.010 |
Why?
|
Vitamin D | 1 | 2012 | 3197 | 0.010 |
Why?
|
Pneumonia | 1 | 2009 | 2102 | 0.010 |
Why?
|
Ciliary Neurotrophic Factor | 1 | 1997 | 79 | 0.010 |
Why?
|
Janus Kinase 1 | 1 | 1997 | 104 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9714 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 16646 | 0.010 |
Why?
|
Acute-Phase Proteins | 1 | 1997 | 261 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1997 | 1583 | 0.010 |
Why?
|
Luciferases | 1 | 1997 | 734 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12328 | 0.010 |
Why?
|
Genomics | 1 | 2010 | 5652 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11410 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 1997 | 578 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7274 | 0.010 |
Why?
|
Boston | 1 | 2006 | 9314 | 0.010 |
Why?
|
Mutagenesis | 1 | 1997 | 1265 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40050 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1997 | 1549 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 20913 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 12643 | 0.010 |
Why?
|
Transfection | 1 | 1997 | 5884 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1997 | 2455 | 0.000 |
Why?
|
Trans-Activators | 1 | 1997 | 2922 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1997 | 5863 | 0.000 |
Why?
|
Stem Cells | 1 | 1997 | 3566 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1997 | 7709 | 0.000 |
Why?
|
Cell Line | 1 | 1997 | 15987 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1997 | 13002 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 12049 | 0.000 |
Why?
|